SAB Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $44.2M
Liabilities Breakdown FY2024
Total Liabilities: $18.2M
Asset Breakdown
Total Assets: $44.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.9M | 20.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $15.4M | 34.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $19.9M | 45.1% |
Liabilities Breakdown
Total Liabilities: $18.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 9.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.5M | 90.7% |